Condition: Non-small Cell Lung Cancer · Sponsor: Sun Yat-sen University
EGFR mutation positive advanced NSCLC patients with uncleared ctDNA have poor prognosis, whether they can benefit from combination therapy has not been reported. This study aims to investigate the efficacy and safety of combination therapy compared with furmonertinib monotherapy in advanced EGFR mutant NSCLC with uncleared circulating tumor cell DNA.
This description comes directly from the study's public registry record.
Zhang MD Li, 58 · 13902282893 · zhangli@sysucc.org.cn
Fang Wen Feng, 46 · 15322302066 · fangwf@sysucc.org.cn
Always discuss trial participation with your own doctor first.
| The First Hospital of Jilin University | Changchun, China | Not Yet Recruiting |
| Sichuan Provincial People's Hospital | Chengdu, China | Not Yet Recruiting |
| Dongguan People's Hospital | Dongguan, China | Not Yet Recruiting |
| Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang People's hospital | Dongyang, China | Not Yet Recruiting |
| The First People's Hospital of Foshan | Foshan, China | Not Yet Recruiting |
| Affiliated Cancer Hospital and Institute of Guangzhou Medical University | Guangzhou, China | Not Yet Recruiting |
| Nanfang Hospital, Southern Medical University | Guangzhou, China | Not Yet Recruiting |
| Sun Yat-sen University cancer center | Guangzhou, China | Recruiting |
| The First Affiliated Hospital, Sun Yat-sen University | Guangzhou, China | Not Yet Recruiting |
| The First Affiliated Hospital, Zhejiang University School of Medicine | Hangzhou, China | Not Yet Recruiting |
| The Second Affiliated Hospital Zhejiang University School of Medicine | Hangzhou, China | Not Yet Recruiting |
| Zhejiang Provincial Hospital of Chinese Medicine | Hangzhou, China | Not Yet Recruiting |
+ 14 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05334277